Orsolya Horváth

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation

Krisztián Kállay, Csaba Kassa, Marienn Réti et al. · Journal of Immunotherapy · 2017 · 67 citations

Medicine, Hematology, Pediatrics +17

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Ulrich Krafft, Csilla Oláh, Henning Reis et al. · Cancers · 2021 · 65 citations · Full text

Medicine, Immunology, Oncology +17

Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation

Orsolya Horváth, Krisztián Kállay, Dorottya Csuka et al. · Biology of Blood and Marrow Transplantation · 2018 · 41 citations · Full text

Life Sciences, Hematology, Immunology +16

D-Dimer as a Potential Prognostic Marker

Zsuzsanna Nagy, Orsolya Horváth, Julia Kádas et al. · Pathology & Oncology Research · 2012 · 30 citations

Medicine, Biomedical Sciences, Molecular Diagnostics +4

Validation of Early Increase in Complement Activation Marker sC5b-9 as a Predictive Biomarker for the Development of Thrombotic Microangiopathy After Stem Cell Transplantation

Blanka Mező, Orsolya Horváth, György Sinkovits et al. · Frontiers in Medicine · 2020 · 30 citations · Full text

Medicine, Hematology, Pediatrics +15